We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Pathologists Use Spatial Light Interference Microscopy to Predict Risk of Prostate Cancer Recurrence Prior to Biopsy or Surgery

By LabMedica International staff writers
Posted on 24 May 2015
Image: Left: Quantitative phase image of an unstained prostatectomy sample from a patient who had a biochemical recurrence of prostate cancer. Right: A zoomed-in region from the quantitative phase image showing a cancerous gland with debris in the lumen. The stroma, or supportive tissue environment, shows discontinuities in the fiber length and disorganization in the orientation of the fibers (Photo courtesy of the University of Illinois).
Image: Left: Quantitative phase image of an unstained prostatectomy sample from a patient who had a biochemical recurrence of prostate cancer. Right: A zoomed-in region from the quantitative phase image showing a cancerous gland with debris in the lumen. The stroma, or supportive tissue environment, shows discontinuities in the fiber length and disorganization in the orientation of the fibers (Photo courtesy of the University of Illinois).
A novel microscopy method that combines phase contrast microscopy with holography enables prediction of the likelihood of prostate cancer recurrence prior to biopsy or surgery.

The method is called spatial light interference microscopy or SLIM. SLIM uses a commercial phase contrast microscope and white light illumination, resulting in nanometer scale sensitivity to optical path-length shifts. In essence, SLIM combines phase contrast microscopy with holography.

Investigators at the University of Illinois (Urbana, USA) have introduced a new instrument for SLIM imaging. Their real-time fast SLIM technique could image at a maximum rate of 50 frames per second and provided real-time quantitative phase images at 12.5 frames per second. They were able to achieve this fast rate by combining rapid LCPM (linear pulse-code modulation) and a fast sCMOS camera. In addition, they developed the software to perform phase reconstruction and display the quantitative phase images in real-time.

In the current study, the investigators used the SLIM technique to examine 181 tissue samples obtained from the [US] National Cancer Institute-sponsored Cooperative Prostate Tissue Resource (CPCTR), The specimens were taken from individuals who had a prostatectomy, approximately half who had no recurrence and half who did.

The instrument was programmed to scan microscope slides containing 320–360 individual cores. The resulting SLIM image contained rich information about tissue morphology, with the glandular epithelium and stroma structures clearly resolved. This allowed the investigators to interrogate scattering changes specific to prostate stroma.

Results suggested that SLIM showed promise in assisting pathologists to improve prediction of prostate cancer recurrence. The data revealed that a lower value of anisotropy corresponded to a higher risk for recurrence, meaning that the stroma adjoining the glands of recurrent patients was more fractionated than in non-recurrent patients. Anisotropy is the property of being directionally dependent, as opposed to isotropy, which implies identical properties in all directions. It can be defined as a difference, when measured along different axes, in a material's physical or mechanical properties.

"For every 20 surgery procedures to take out the prostate, it is estimated that only one life is saved," said senior author Dr. Gabriel Popescu, associate professor of electrical and computer engineering at the University of Illinois. "For the other 19 people, they would be better left alone, because with removing the prostate, the quality of life goes down dramatically. So if you had a tool that could tell which patient will actually be more likely to have a bad outcome, then you could more aggressively treat that case."

"What SLIM is very good at is to make invisible objects visible with nanoscale sensitivity," said Dr. Popescu. "So we pick these structural details without the need for staining, which can introduce new variables into the specimen. Our dream is for everyone to have SLIM capabilities in their labs. One can imagine that a SLIM-based tissue imager will scan biopsies in a clinic and, paired with software that is intelligent enough to look for these specific markers, will provide the pathologist with valuable new information. This additional information will translate into more accurate diagnosis and prognosis."

The paper describing the use of SLIM to predict prostate cancer recurrence was published in the May 15, 2015, online edition of the journal Scientific Reports.

Related Links:

University of Illinois


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
POC Immunoassay Analyzer
Procise DX

Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more